AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 144 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $399,000 | +358.6% | 142,482 | +312.8% | 0.00% | – |
| Q3 2020 | $87,000 | -71.3% | 34,512 | +54.6% | 0.00% | – |
| Q2 2020 | $303,000 | -48.7% | 22,328 | -71.4% | 0.00% | -100.0% |
| Q1 2020 | $591,000 | -60.0% | 77,961 | -56.8% | 0.00% | 0.0% |
| Q1 2019 | $1,478,000 | -57.0% | 180,482 | -47.6% | 0.00% | -66.7% |
| Q2 2018 | $3,438,000 | -28.0% | 344,447 | -31.2% | 0.00% | -40.0% |
| Q1 2018 | $4,774,000 | -9.1% | 500,971 | +41.9% | 0.01% | 0.0% |
| Q4 2017 | $5,251,000 | +23.8% | 353,111 | +63.8% | 0.01% | +25.0% |
| Q3 2017 | $4,240,000 | +218.6% | 215,544 | +132.7% | 0.00% | +300.0% |
| Q2 2017 | $1,331,000 | – | 92,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |